StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SRXH$0.12+7.21%
Fair $0.12+0.0%

SRXH

SRx Health Solutions Inc.

Consumer Defensive / Packaged FoodsNYSE American

$0.12

+0.01 (+7.21%)

Fairly Valued+0.0%Fair Value $0.12Fund rank 17/100 · Data gapFallback financials|
SA 9/F
F-Score: 2/9
High DebtLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-1.5M · quality 16.0/100

Data gap 17/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 9/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

9/100

F

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 25Warnings: 2unknown: 25
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Debt-to-Equity ratio is 10.99, above the 2.0 threshold ROE is -110.6%, below the 5% threshold
Thesis & Journal · SRXHLocal privado en este navegador · SRx Health Solutions Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$70M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-11058.0%

↓

Gross Margin

23.4%

↓

Debt/Equity

10.99

↑
52-Week Range$0
$0$1

TradingView lightweight chart

SRXH price, volumen y niveles de valoración

Último $0.119Periodo -100.0%
Fair value: $0.119

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2001–2025 · 24 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

-156.4%

FCF / Net income

0.23x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $6.5M · net income $-45.0M · FCF $-10.2M

2001-FY → 2025-FY

Gross margin

23.4%— pts

Operating margin

-174.6%— pts

Net margin

-688.8%— pts

FCF margin

-156.4%— pts
MetricTTM
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
Income Statement
Revenue$6.5M$6.5M—$38.6M$54.7M$46.0M$42.6M$15.6M$14.8M$1400.00$43.00$0.00$0.00$0.00$0.00$0.00——————————
Net Income$-45.0M$-45.0M$-43.1M$-22.8M$-39.3M$3.4M$-59.3M$-184.5M$-6.0M$-1.7M$-933761.00$-49669.00$-51237.00$-94170.00$-15909.00$-40847.00$-38421.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-125000.00$-16200.00
EBITDA$-8.0M$-8.0M$4.4M$-19.5M$-37.1M$-15.6M$-25.6M$-36.2M$-5.1M$-524038.00$-457492.00$-22464.00$-23083.00$-17888.00$-9025.00$-35039.00——————————
EPS-1.81-1.81-3.01-23.92-43.654.15-215.11——-92.44-46.220.000.00-7210.67-1201.78-3143.11——————————
Gross Margin23.4%23.4%—30.6%27.9%33.4%37.8%37.6%49.3%100.0%————————————————
Operating Margin-174.6%-174.6%—-54.9%-71.0%-37.6%-64.2%-233.2%-34.9%-37431.3%-1069027.9%———————————————
Net Margin-688.8%-688.8%—-59.0%-71.9%7.4%-139.3%-1184.2%-40.8%-124518.4%-2171537.2%———————————————
Balance Sheet
Debt/Equity10.9910.99-0.821.550.530.16-0.88-2.32-2.040.00————————————————
Current Ratio1.721.72————————————————————————
Cash Flow
Free Cash Flow$-10.2M$-10.2M$-1.5M$79000.00$-20.8M$-12.2M$-7.7M$-21.1M$-6.9M—————————————————
Returns
ROE-11058.0%-11058.0%78.1%-764.6%-182.6%5.9%211.1%2608.7%198.1%147.4%162.6%2.1%155.2%116.6%28.5%102.3%-4273.7%0.0%————————
Valuation
EV/EBITDA——15.11———————————————————————
P/B7.287.28————————————————————————
Growth & Yield
Revenue Growth———-29.4%18.8%8.0%173.4%5.4%1055971.4%3155.8%————————————————
EPS Growth40.0%40.0%—45.2%-1152.3%101.9%———-100.0%——100.0%-500.0%61.8%———————————

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -78.1%

Total return

-78.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-3.01 → -1.81

Residual

-78.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-78.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.